Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-005539
Filing Date
2025-02-21
Accepted
2025-02-21 21:05:31
Documents
1
Period of Report
2025-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5650
  Complete submission text file 0001140361-25-005539.txt   7261
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Issuer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 135 ROUTE 202/206 BEDMINSTER NJ 07921
Business Address
Salas Eduardo Rene (Reporting) CIK: 0001924188 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36728 | Film No.: 25653947